Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification
Open Access
Abstract
Background: miRNAs play a crucial role in the anti-inflammatory effects of inhaled corticosteroids (ICS) in asthma. Vitamin D can modulate the expression of several miRNAs and reduces asthma exacerbations, but its molecular interaction with ICS remains unclear. Objective: We hypothesised that vitamin D influences long-term ICS response through miRNA regulation. Methods: Baseline serum miRNAs were sequenced from 462 subjects in the Childhood Asthma Management Program (CAMP), with 187 randomised to ICS treatment included in this study. Linear regression assessed associations between miRNA expression and prebronchodilator forced expiratory volume in 1 s per cent predicted (FEV 1 %) change over 4 years, stratified by baseline vitamin D levels and tested in interaction models. Microarray analysis of lymphoblastoid B cells (lymphoblastoid cell lines (LCLs)) from 22 CAMP subjects treated with dexamethasone (DEX), vitamin D or sham identified differentially expressed genes (DEGs). An miRNA target gene network was constructed, clustered and annotated by enrichment analysis. Top miRNAs were evaluated for ICS response prediction. Results: 12 miRNAs were significantly associated with ICS-mediated FEV 1 % change in vitamin D insufficient subjects, and 11 miRNAs showed significant interaction with vitamin D (p≤0.05). Three miRNAs were approximately replicated in the Genetics of Asthma in Costa Rica Study. Microarray analysis identified 220 and 240 DEGs in DEX and vitamin D-treated LCLs, respectively. miRNAs hsa-miR-125a-5p, hsa-miR-181a-5p, hsa-miR-101-3p and hsa-miR-107 were enriched in haemopoiesis and leucocyte differentiation pathways (p≤0.05). Two miRNAs, hsa-miR-125a-5p and hsa-miR-181a-5p, predicted ICS response with an area under the receiver operating characteristic curve of 0.86 in the vitamin D insufficient group. Conclusions: Vitamin D may modulate ICS response through miRNAs involved in immune cell differentiation, which could serve as biomarkers for ICS response, particularly in vitamin D insufficient individuals.Keywords
Funding Information
- National Institutes of Health (R01 HL127332, R01 HL129935, R01 HL139634, R01 HL162570)
- Guangdong Medical Science and Technology Research Fund (A2024136)
- Seventh Affiliated Hospital of Sun Yan-Sen University (ZSQYBRJH0024)
- Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research (ZDSYS20220606100801003)
- Shenzhen Science and Technology Program (JCYJ20230807110302006)
This publication has 40 references indexed in Scilit:
- miRNAome-metabolome wide association study reveals effects of miRNA regulation in eosinophilia and airflow obstruction in childhood asthmaEBioMedicine, 2024
- A novel piwi-interacting RNA associates with type 2–high asthma phenotypesJournal of Allergy and Clinical Immunology, 2023
- Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopeniaGenes & Immunity, 2023
- Vitamin D3 resolved human and experimental asthma via B lymphocyte–induced maturation protein 1 in T cells and innate lymphoid cellsJournal of Allergy and Clinical Immunology: Global, 2023
- Early life miRNA programming of asthma and allergic diseasesJournal of Allergy and Clinical Immunology, 2023
- AsthmaThe Lancet, 2023
- Decreased Treg-derived miR-181a and miR-155 correlated with reduced number and function of Treg cells in allergic rhinitis childrenEuropean Archives of Oto-Rhino-Laryngology, 2019
- Non-genomic Effects of Glucocorticoids: An Updated ViewTrends in Pharmacological Sciences, 2019
- TGF-β receptors: In and beyond TGF-β signalingCellular Signalling, 2018
- Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashionJournal of Allergy and Clinical Immunology, 2013